How Artificial Intelligence Is Transforming Clinical Research Operations in 2026 — and How You Can Lead That Change
No technical background required. If you work in clinical research, this session is for you.
I've spent my career at the intersection of clinical research and technology — watching brilliant teams struggle with the same preventable problems: drowning in documents, inconsistent data, audit anxiety, and a training gap that's widening every year. Aurelyn AI Clinical exists because that suffering is optional.
If you check even one of these, you're in exactly the right place.
These aren't just statistics. Behind every number is a delayed patient, a burned-out team, and a budget overrun.
A single Phase III trial generates 50,000–100,000+ documents. Most teams manage them in spreadsheets, shared drives, and email threads.
Across sites, protocols, and teams — clinical data inconsistency is the silent trial killer.
Inconsistency isn't a people problem — it's a systems problem. And AI is the system designed to solve it.
The industry needs 280,000+ new clinical research professionals by 2028. The training infrastructure hasn't kept up.
The question is no longer "Can we afford AI?" — it's "Can we afford not to?"
Imagine starting your Monday knowing that every TMF document is classified correctly. Every protocol deviation is caught in real-time. Every team member has training that's tailored to exactly where they are in their career.
This isn't science fiction. This is the Aurelyn AI Clinical Trial OS™.
No jargon. No hype. Just a plain-English explanation of what modern AI does — and what it doesn't replace.
A unified, AI-powered operating system purpose-built for clinical research — covering every layer of your operations.
AI-powered TMF classification, completeness monitoring, and inspection-readiness — running 24/7 in the background.
Real-time data quality surveillance and cross-site harmonization — catching inconsistencies before they become protocol deviations.
Structured, accredited AI education designed for clinical research professionals — from CRA to C-Suite.
Strategic guidance from experts who've lived in both worlds — clinical research and AI technology.
One platform. Every role. Every stage of the trial lifecycle.
Every feature of the Aurelyn Clinical Trial OS™ is designed to align with — not circumvent — regulatory expectations.
| REGULATION / FRAMEWORK | WHAT IT COVERS | HOW WE ALIGN | STATUS |
|---|---|---|---|
| ICH E6(R3) | GCP guidelines for clinical trials | TMF completeness, risk-based monitoring, data integrity checks | ✓ Full Alignment |
| 21 CFR Part 11 | FDA electronic records & signatures | Audit trails, e-signature workflows, access controls, validation docs | ✓ Full Alignment |
| EU AI Act (2026) | AI system governance in regulated industries | Transparency documentation, human oversight, bias monitoring | ✓ Full Alignment |
| ALCOA+ | Data integrity principles | Automated traceability, contemporaneous records, complete audit logs | ✓ Full Alignment |
| NIST AI RMF | AI risk management framework | Risk categorization, validation protocols, incident response workflows | ✓ Full Alignment |
| TMF Reference Model | Industry standard TMF structure | Auto-classification against 800+ document zones, artifacts, and metadata | ✓ Full Alignment |
We don't add compliance as an afterthought. Regulatory alignment is the foundation everything else is built on.
Whether you're brand new to AI or already exploring tools — here's a proven roadmap that works regardless of your starting point.
90 days from now, your team is either ahead of the curve or still filing manually. The choice is yours — starting today.
Three ways to move forward — pick the one that fits where you are right now.
These offers are for webinar attendees only. They won't be available after today.
This is your time. Ask anything — about AI, about your specific situation, about the platform, or about how to get leadership buy-in at your organization.
Thank you for being here. The future of clinical research is intelligent — and it starts now.